Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer


About this study

This study will evaluate feasibility and acceptability of providing the Dignity Therapy/Life Plan intervention to pancreatic or advanced lung cancer patients presenting for treatment in the outpatient medical oncology setting. Investigators hypothesize that providing dignity therapy to this population will be feasible.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age >18
  • Undergoing chemotherapy for pancreatic adenocarcinoma or advanced NSCLC (pancreatic arm closed)
  • English-speaking
  • Cognitively intact, per clinician judgment, as documented in electronic medical record (EMR)

Exclusion Criteria:

  • Currently receiving hospice or palliative care services
  • Concurrent diagnosis of delirium or dementia, per medical record
  • Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record
  • Participating in other psychosocial intervention research studies

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ann Dose, Ph.D., R.N.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions